Claris Lifesciences informs about outcome of board meeting

16 Dec 2016 Evaluate

Claris Lifesciences has informed that the Board of Directors of the Company at the meeting held on December 15, 2016 (commenced at 5:00 PM and concluded at 6:30 PM) has approved the sale and transfer of the Injectable Business of Claris Lifesciences Limited (CLL or the Company) by way of sale of the subsidiary companies Claris Injectables Limited, Claris Pharmaservices, Elda International DMCC, Claris Lifesciences Inc., Claris Lifesciences (UK) Limited, Claris Lifesciences (Aust) Pty. Limited, Claris Lifesciences Philippines, INC.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Redington 194.70
Adani Enterprises 2229.65
Amrapali Industries 18.23
Rashi Peripheral 371.05
Compuage Infocom 2.58
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.